[Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
D000368:Aged; D002208:Caproates / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006908:Hydroxyprogesterones / Q000494:pharmacology; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D011278:Pregnanes / Q000009:adverse effects / Q000627:therapeutic use*; D011467:Prostate / Q000033:anatomy & histology / Q000187:drug effects; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D014054:Tomography; D014463:Ultrasonography
D002208:Caproates; D006908:Hydroxyprogesterones; D011278:Pregnanes